You have free access to this content

Hepatology

Cover image for Vol. 59 Issue 3

March 2014

Volume 59, Issue 3

Pages 741–1216

  1. Comments from the Editors

    1. Top of page
    2. Comments from the Editors
    3. Hepatology Highlights
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Practice Guidelines
    13. New Horizons
    14. Review
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Faster than a speeding bullet (pages 741–742)

      Donald M. Jensen and Michael H. Nathanson

      Version of Record online: 4 FEB 2014 | DOI: 10.1002/hep.27007

  2. Hepatology Highlights

    1. Top of page
    2. Comments from the Editors
    3. Hepatology Highlights
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Practice Guidelines
    13. New Horizons
    14. Review
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Hepatology highlights (pages 743–745)

      Jean-François Dufour

      Version of Record online: 25 FEB 2014 | DOI: 10.1002/hep.27021

  3. Editorials

    1. Top of page
    2. Comments from the Editors
    3. Hepatology Highlights
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Practice Guidelines
    13. New Horizons
    14. Review
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. Corrections
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
      Autoimmune hepatitis: 50 years of (slow) progress (pages 754–756)

      M. Eric Gershwin and Edward L. Krawitt

      Version of Record online: 27 JAN 2014 | DOI: 10.1002/hep.26682

    5. You have free access to this content
      Painting the liver with lasers: The future of liver histology? (pages 757–760)

      Diren Beyoğlu and Jeffrey R. Idle

      Version of Record online: 4 DEC 2013 | DOI: 10.1002/hep.26734

    6. You have free access to this content
    7. You have free access to this content
  4. Viral Hepatitis

    1. Top of page
    2. Comments from the Editors
    3. Hepatology Highlights
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Practice Guidelines
    13. New Horizons
    14. Review
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: Prospective analysis of 435 liver biopsy pairs (pages 767–775)

      Monica A. Konerman, Shruti H. Mehta, Catherine G. Sutcliffe, Trang Vu, Yvonne Higgins, Michael S. Torbenson, Richard D. Moore, David L. Thomas and Mark S. Sulkowski

      Version of Record online: 16 JAN 2014 | DOI: 10.1002/hep.26741

    2. You have free access to this content
      Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry (pages 776–788)

      Florian Douam, Viet Loan Dao Thi, Guillemette Maurin, Judith Fresquet, Dimitri Mompelat, Mirjam B. Zeisel, Thomas F. Baumert, François-Loïc Cosset and Dimitri Lavillette

      Version of Record online: 28 JAN 2014 | DOI: 10.1002/hep.26733

    3. You have free access to this content
      Infection of common marmosets with hepatitis C virus/GB virus-B chimeras (pages 789–802)

      Tingting Li, Shaomei Zhu, Lifang Shuai, Yuxia Xu, Sen Yin, Yixin Bian, Yuanzhan Wang, Bingfeng Zuo, Wenjing Wang, Shuoxian Zhao, Ling Zhang, Jingang Zhang, George F. Gao, Jean-Pierre Allain and Chengyao Li

      Version of Record online: 16 JAN 2014 | DOI: 10.1002/hep.26750

    4. You have free access to this content
      Hepatitis C virus clearance correlates with HLA-DR expression on proliferating CD8+ T cells in immune-primed chimpanzees (pages 803–813)

      Iryna Zubkova, Hongying Duan, Frances Wells, Howard Mostowski, Esther Chang, Kathleen Pirollo, Kris Krawczynski, Robert Lanford and Marian Major

      Version of Record online: 28 JAN 2014 | DOI: 10.1002/hep.26747

    5. You have free access to this content
      An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients (pages 814–827)

      Pavlos Kokordelis, Benjamin Krämer, Christian Körner, Christoph Boesecke, Esther Voigt, Patrick Ingiliz, Andreas Glässner, Marianne Eisenhardt, Franziska Wolter, Dominik Kaczmarek, Hans Dieter Nischalke, Jürgen K. Rockstroh, Ulrich Spengler and Jacob Nattermann

      Version of Record online: 21 JAN 2014 | DOI: 10.1002/hep.26782

    6. You have free access to this content
      Hepatic interferon-stimulated genes are differentially regulated in the liver of chronic hepatitis C patients with different interleukin-28B genotypes (pages 828–838)

      Masao Honda, Takayoshi Shirasaki, Tetsuro Shimakami, Akito Sakai, Rika Horii, Kuniaki Arai, Tatsuya Yamashita, Yoshio Sakai, Taro Yamashita, Hikari Okada, Kazuhisa Murai, Mikiko Nakamura, Eishiro Mizukoshi and Shuichi Kaneko

      Version of Record online: 27 JAN 2014 | DOI: 10.1002/hep.26788

  5. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Comments from the Editors
    3. Hepatology Highlights
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Practice Guidelines
    13. New Horizons
    14. Review
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis (pages 839–847)

      Edouard Bardou-Jacquet, Julie Philip, Richard Lorho, Martine Ropert, Marianne Latournerie, Pauline Houssel-Debry, Dominique Guyader, Olivier Loréal, Karim Boudjema and Pierre Brissot

      Version of Record online: 27 JAN 2014 | DOI: 10.1002/hep.26570

    2. You have free access to this content
      Ductular reaction in hereditary hemochromatosis: The link between hepatocyte senescence and fibrosis progression (pages 848–857)

      Marnie J. Wood, Victoria L. Gadd, Lawrie W. Powell, Grant A. Ramm and Andrew D. Clouston

      Version of Record online: 27 JAN 2014 | DOI: 10.1002/hep.26706

    3. You have free access to this content
      Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia (pages 858–869)

      Pooja Jha, Thierry Claudel, Anna Baghdasaryan, Michaela Mueller, Emina Halilbasic, Suman K. Das, Achim Lass, Robert Zimmermann, Rudolf Zechner, Gerald Hoefler and Michael Trauner

      Version of Record online: 28 JAN 2014 | DOI: 10.1002/hep.26732

    4. You have free access to this content
      Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance (pages 870–885)

      Xin-An Wang, Ran Zhang, Zhi-Gang She, Xiao-Fei Zhang, Ding-Sheng Jiang, Tao Wang, Lu Gao, Wei Deng, Shu-Min Zhang, Li-Hua Zhu, Sen Guo, Ke Chen, Xiao-Dong Zhang, De-Pei Liu and Hongliang Li

      Version of Record online: 30 JAN 2014 | DOI: 10.1002/hep.26751

    5. You have free access to this content
      Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH (pages 886–897)

      Salvatore Sutti, Aastha Jindal, Irene Locatelli, Marco Vacchiano, Luca Gigliotti, Cristina Bozzola and Emanuele Albano

      Version of Record online: 16 JAN 2014 | DOI: 10.1002/hep.26749

    6. You have free access to this content
      NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice (pages 898–910)

      Alexander Wree, Akiko Eguchi, Matthew D. McGeough, Carla A. Pena, Casey D. Johnson, Ali Canbay, Hal M. Hoffman and Ariel E. Feldstein

      Version of Record online: 30 JAN 2014 | DOI: 10.1002/hep.26592

  6. Hepatobiliary Malignancies

    1. Top of page
    2. Comments from the Editors
    3. Hepatology Highlights
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Practice Guidelines
    13. New Horizons
    14. Review
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients (pages 911–923)

      Luca Quagliata, Matthias S. Matter, Salvatore Piscuoglio, Leila Arabi, Christian Ruiz, Alfredo Procino, Michal Kovac, Francesca Moretti, Zuzanna Makowska, Tujana Boldanova, Jesper B. Andersen, Monika Hämmerle, Luigi Tornillo, Markus H. Heim, Sven Diederichs, Clemente Cillo and Luigi M. Terracciano

      Version of Record online: 28 JAN 2014 | DOI: 10.1002/hep.26740

    2. You have free access to this content
      Organized proteomic heterogeneity in colorectal cancer liver metastases and implications for therapies (pages 924–934)

      Andrei Turtoi, Arnaud Blomme, Delphine Debois, Joan Somja, David Delvaux, Georgios Patsos, Emmanuel Di Valentin, Olivier Peulen, Eugène Nzaramba Mutijima, Edwin De Pauw, Philippe Delvenne, Olivier Detry and Vincent Castronovo

      Version of Record online: 16 DEC 2013 | DOI: 10.1002/hep.26608

    3. You have free access to this content
      Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma (pages 935–946)

      Tongsen Zheng, Xuehui Hong, Jiabei Wang, Tiemin Pei, Yingjian Liang, Dalong Yin, Ruipeng Song, Xuan Song, Zhaoyang Lu, Shuyi Qi, Jiaren Liu, Boshi Sun, Changming Xie, Shangha Pan, Yuejin Li, Xiaohe Luo, Shuai Li, Xiang Fang, Nishant Bhatta, Hongchi Jiang and Lianxin Liu

      Version of Record online: 29 JAN 2014 | DOI: 10.1002/hep.26705

    4. You have free access to this content
      Liver-specific knockout of GRP94 in mice disrupts cell adhesion, activates liver progenitor cells, and accelerates liver tumorigenesis (pages 947–957)

      Wan-Ting Chen, Chun-Chih Tseng, Kyle Pfaffenbach, Gary Kanel, Biquan Luo, Bangyan L. Stiles and Amy S. Lee

      Version of Record online: 27 JAN 2014 | DOI: 10.1002/hep.26711

    5. You have free access to this content
      Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression (pages 958–973)

      Limin Xia, Wenjie Huang, Dean Tian, Lin Zhang, Xingshun Qi, Zhangqian Chen, Xin Shang, Yongzhan Nie and Kaichun Wu

      Version of Record online: 6 FEB 2014 | DOI: 10.1002/hep.26735

    6. You have free access to this content
      Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment (pages 974–985)

      Chi-Kuan Chen, Ching-Yao Yang, Kuo-Tai Hua, Ming-Chih Ho, Gunnar Johansson, Yung-Ming Jeng, Chiung-Nien Chen, Min-Wei Chen, Wei-Jiunn Lee, Jen-Liang Su, Tsung-Ching Lai, Chi-Chi Chou, Bing-Ching Ho, Chuan-Fa Chang, Po-Huang Lee, King-Jen Chang, Michael Hsiao, Ming-Tsan Lin and Min-Liang Kuo

      Version of Record online: 16 JAN 2014 | DOI: 10.1002/hep.26738

      Corrected by:

      Corrections: Corrections

      Vol. 59, Issue 5, 2058, Version of Record online: 23 APR 2014

    7. You have free access to this content
      On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir (pages 986–995)

      Grace L.H. Wong, Henry L.Y. Chan, Yee-Kit Tse, Hoi-Yun Chan, Chi-Hang Tse, Angeline O.S. Lo and Vincent W.S. Wong

      Version of Record online: 30 JAN 2014 | DOI: 10.1002/hep.26739

    8. You have free access to this content
      Diagnostic accuracy of 18F-methylcholine positron emission tomography/computed tomography for intra- and extrahepatic hepatocellular carcinoma (pages 996–1006)

      Matthanja Bieze, Heinz-Josef Klümpen, Joanne Verheij, Ulrich Beuers, Saffire S.K.S. Phoa, Thomas M. van Gulik and Roelof J. Bennink

      Version of Record online: 30 JAN 2014 | DOI: 10.1002/hep.26781

  7. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Comments from the Editors
    3. Hepatology Highlights
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Practice Guidelines
    13. New Horizons
    14. Review
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Dysfunctional CD39POS regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis (pages 1007–1015)

      Charlotte R. Grant, Rodrigo Liberal, Beth S. Holder, John Cardone, Yun Ma, Simon C. Robson, Giorgina Mieli-Vergani, Diego Vergani and Maria Serena Longhi

      Version of Record online: 30 JAN 2014 | DOI: 10.1002/hep.26583

    2. You have free access to this content
      G-protein-coupled receptor 30/adenylyl cyclase/protein kinase A pathway is involved in estradiol 17ß-d-glucuronide-induced cholestasis (pages 1016–1029)

      Andrés E. Zucchetti, Ismael R. Barosso, Andrea C. Boaglio, Cecilia L. Basiglio, Gisel Miszczuk, M. Cecilia Larocca, M. Laura Ruiz, Carlos A. Davio, Marcelo G. Roma, Fernando A. Crocenzi and Enrique J. Sánchez Pozzi

      Version of Record online: 21 JAN 2014 | DOI: 10.1002/hep.26752

    3. You have free access to this content
  8. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Comments from the Editors
    3. Hepatology Highlights
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Practice Guidelines
    13. New Horizons
    14. Review
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Serum B-type natriuretic peptide in the initial workup of patients with new onset ascites: A diagnostic accuracy study (pages 1043–1051)

      Alberto Q. Farias, Odilson M. Silvestre, Guadalupe Garcia-Tsao, Luis F.B. da Costa Seguro, Daniel F. de Campos Mazo, Fernando Bacal, José L. Andrade, Luciana L. Gonçalves, Célia Strunz, Danusa S. Ramos, Demerson Polli, Vincenzo Pugliese, Ana C.T. Rodrigues, Meive S. Furtado, Flair J. Carrilho and Luiz A.C. D'Albuquerque

      Version of Record online: 13 JAN 2014 | DOI: 10.1002/hep.26643

      Corrected by:

      Corrections: Corrections

      Vol. 59, Issue 5, 2058, Version of Record online: 23 APR 2014

    2. You have free access to this content
      Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients (pages 1052–1059)

      Martina Buck, Guadalupe Garcia-Tsao, Roberto J. Groszmann, Caitlin Stalling, Norman D. Grace, Andrew K. Burroughs, David Patch, Daniel S. Matloff, Paul Clopton and Mario Chojkier

      Version of Record online: 29 JAN 2014 | DOI: 10.1002/hep.26755

    3. You have free access to this content
      Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C+ macrophage infiltration in mice (pages 1060–1072)

      Christer Baeck, Xiao Wei, Matthias Bartneck, Viktor Fech, Felix Heymann, Nikolaus Gassler, Kanishka Hittatiya, Dirk Eulberg, Tom Luedde, Christian Trautwein and Frank Tacke

      Version of Record online: 30 JAN 2014 | DOI: 10.1002/hep.26783

    4. You have full text access to this OnlineOpen article
      Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy (pages 1073–1083)

      Don C. Rockey, John M. Vierling, Parvez Mantry, Marwan Ghabril, Robert S. Brown Jr., Olga Alexeeva, Igor A. Zupanets, Vladimir Grinevich, Andrey Baranovsky, Larysa Dudar, Galyna Fadieienko, Nataliya Kharchenko, Iryna Klaryts'ka, Vyacheslav Morozov, Priya Grewal, Timothy McCashland, K. Gautham Reddy, K. Rajender Reddy, Vasyl Syplyviy, Nathan M. Bass, Klara Dickinson, Catherine Norris, Dion Coakley, Masoud Mokhtarani, Bruce F. Scharschmidt and for the HALT-HE Study Group

      Version of Record online: 25 FEB 2014 | DOI: 10.1002/hep.26611

  9. Liver Injury/Regeneration

    1. Top of page
    2. Comments from the Editors
    3. Hepatology Highlights
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Practice Guidelines
    13. New Horizons
    14. Review
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Detection of anti-isoniazid and anti–cytochrome P450 antibodies in patients with isoniazid-induced liver failure (pages 1084–1093)

      Imir G. Metushi, Corron Sanders, The Acute Liver Study Group, William M. Lee and Jack Uetrecht

      Version of Record online: 27 JAN 2014 | DOI: 10.1002/hep.26564

    2. You have free access to this content
      Opposing effects of prednisolone treatment on T/NKT cell- and hepatotoxin-mediated hepatitis in mice (pages 1094–1106)

      Hyo-Jung Kwon, Young-Suk Won, Ogyi Park, Dechun Feng and Bin Gao

      Version of Record online: 21 JAN 2014 | DOI: 10.1002/hep.26748

  10. Liver Biology/Pathobiology

    1. Top of page
    2. Comments from the Editors
    3. Hepatology Highlights
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Practice Guidelines
    13. New Horizons
    14. Review
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Endothelin-1 receptor A blocker darusentan decreases hepatic changes and improves liver repopulation after cell transplantation in rats (pages 1107–1117)

      Ralf Bahde, Sorabh Kapoor, Preeti Viswanathan, Hans-Ullrich Spiegel and Sanjeev Gupta

      Version of Record online: 16 JAN 2014 | DOI: 10.1002/hep.26766

    2. You have free access to this content
      Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells (pages 1118–1129)

      Li Chen, Alyssa Charrier, Yu Zhou, Ruju Chen, Bo Yu, Kitty Agarwal, Hidekazu Tsukamoto, L. James Lee, Michael E. Paulaitis and David R. Brigstock

      Version of Record online: 27 JAN 2014 | DOI: 10.1002/hep.26768

    3. You have free access to this content
      Small proline rich protein 2a in benign and malignant liver disease (pages 1130–1143)

      Yoshiaki Mizuguchi, Kumiko Isse, Susan Specht, John G. Lunz III, Natasha Corbitt, Toshihiro Takizawa and Anthony J. Demetris

      Version of Record online: 27 JAN 2014 | DOI: 10.1002/hep.26889

  11. Practice Guidelines

    1. Top of page
    2. Comments from the Editors
    3. Hepatology Highlights
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Practice Guidelines
    13. New Horizons
    14. Review
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. Corrections
    1. You have free access to this content
  12. New Horizons

    1. Top of page
    2. Comments from the Editors
    3. Hepatology Highlights
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Practice Guidelines
    13. New Horizons
    14. Review
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Fibroblast growth factor signaling in liver carcinogenesis (pages 1166–1173)

      Dalbir S. Sandhu, Esha Baichoo and Lewis R. Roberts

      Version of Record online: 20 DEC 2013 | DOI: 10.1002/hep.26679

  13. Review

    1. Top of page
    2. Comments from the Editors
    3. Hepatology Highlights
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Practice Guidelines
    13. New Horizons
    14. Review
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Extrahepatic complications of nonalcoholic fatty liver disease (pages 1174–1197)

      Matthew J. Armstrong, Leon A. Adams, Ali Canbay and Wing-Kin Syn

      Version of Record online: 16 JAN 2014 | DOI: 10.1002/hep.26717

  14. Hepatology Elsewhere

    1. Top of page
    2. Comments from the Editors
    3. Hepatology Highlights
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Practice Guidelines
    13. New Horizons
    14. Review
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Role of TWEAK in coregulating liver progenitor cell and fibrogenic responses (pages 1198–1201)

      Janina E.E. Tirnitz-Parker, John K. Olynyk and Grant A. Ramm

      Version of Record online: 27 JAN 2014 | DOI: 10.1002/hep.26701

    2. You have free access to this content
  15. Clinical Observations in Hepatology

    1. Top of page
    2. Comments from the Editors
    3. Hepatology Highlights
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Practice Guidelines
    13. New Horizons
    14. Review
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. Corrections
    1. You have full text access to this OnlineOpen article
  16. Correspondence

    1. Top of page
    2. Comments from the Editors
    3. Hepatology Highlights
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Practice Guidelines
    13. New Horizons
    14. Review
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Interleukin-22 serum levels are a negative prognostic indicator in patients with hepatocellular carcinoma (page 1207)

      Oliver Waidmann, Bernd Kronenberger, Patrick Scheiermann, Verena Köberle, Heiko Mühl and Albrecht Piiper

      Version of Record online: 13 DEC 2013 | DOI: 10.1002/hep.26528

    2. You have free access to this content
      Reply (page 1208)

      Runqiu Jiang, Chuanyong Zhang, Yongxiang Xia, Xiaofeng Qian, Xuehao Wang and Beicheng Sun

      Version of Record online: 29 JAN 2014 | DOI: 10.1002/hep.26613

    3. You have full text access to this OnlineOpen article
      Mixed genotype hepatitis C infections and implications for treatment (page 1209)

      Anna L. McNaughton, Emma C. Thomson, Kate Templeton, Rory N. Gunson and E. Carol McWilliam Leitch

      Version of Record online: 13 JAN 2014 | DOI: 10.1002/hep.26544

    4. You have free access to this content
      Unusual oral mucosa damage during telaprevir treatment of chronic hepatitis C (pages 1209–1210)

      Vasily Isakov, Sergey Morozov and Laurence Valeyrie-Allanore

      Version of Record online: 13 JAN 2014 | DOI: 10.1002/hep.26546

    5. You have free access to this content
      Study of hepatitis B virus quasispecies by ultra-deep pyrosequencing: Resolving the nitty-gritty (pages 1210–1212)

      Francisco-Rodriguez Frias, David Tabernero, Rafael Esteban and Maria Buti

      Version of Record online: 13 JAN 2014 | DOI: 10.1002/hep.26647

      Corrected by:

      Correction: Correction: Study of hepatitis B virus quasispecies by ultra-deep pyrosequencing: resolving the Nitty-Gritty

      Vol. 60, Issue 3, 1117, Version of Record online: 25 AUG 2014

    6. You have free access to this content
      Reply (pages 1212–1213)

      Christophe Rodriguez, Stéphane Chevaliez and Jean-Michel Pawlotsky

      Version of Record online: 13 JAN 2014 | DOI: 10.1002/hep.26646

    7. You have free access to this content
    8. You have free access to this content
    9. You have free access to this content
      Reply (pages 1214–1215)

      James E. Everhart and Elizabeth Wright

      Version of Record online: 13 JAN 2014 | DOI: 10.1002/hep.26650

  17. Corrections

    1. Top of page
    2. Comments from the Editors
    3. Hepatology Highlights
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Practice Guidelines
    13. New Horizons
    14. Review
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. Corrections
    1. You have free access to this content
    2. You have free access to this content
      Correction: Reply: Protein arginine methyltransferase 1 regulates hepatic glucose production in a FoxO1-dependent manner (page 1216)

      Version of Record online: 3 FEB 2014 | DOI: 10.1002/hep.27002

      This article corrects:

      Reply:12

      Vol. 57, Issue 5, 2091, Version of Record online: 22 APR 2013

SEARCH

SEARCH BY CITATION